Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner
Author:
Open Access
- 1 October 2018
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 169, 24-54
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Economía y Competitividad
- Instituto de Salud Carlos III
- European Regional Development Fund (148/16, FIS PI17/00809)
This publication has 438 references indexed in Scilit:
- Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophyActa Neuropathologica, 2012
- C9ORF72, the new gene on the block, causes C9FTD/ALS: new insights provided by neuropathologyActa Neuropathologica, 2011
- Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ‐opioid‐ and nociceptin/orphanin FQ receptors in cell development: Implications for drug addiction treatment during pregnancyGlia, 2011
- Molecular biology and pathology of prion strains in sporadic human prion diseasesActa Neuropathologica, 2010
- Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus‐Merzbacher diseaseEMBO Molecular Medicine, 2010
- Oligodendrocytes: biology and pathologyActa Neuropathologica, 2009
- Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendationsActa Neuropathologica, 2008
- Triple‐transgenic Alzheimer's disease mice exhibit region‐specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathologyGlia, 2008
- Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisAnnals of Neurology, 2008
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991